315 related articles for article (PubMed ID: 19545785)
1. Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy.
van Luijk P; Faber H; Schippers JM; Brandenburg S; Langendijk JA; Meertens H; Coppes RP
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1002-5. PubMed ID: 19545785
[TBL] [Abstract][Full Text] [Related]
2. Volume effects and region-dependent radiosensitivity of the parotid gland.
Konings AW; Cotteleer F; Faber H; van Luijk P; Meertens H; Coppes RP
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1090-5. PubMed ID: 15990013
[TBL] [Abstract][Full Text] [Related]
3. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
[TBL] [Abstract][Full Text] [Related]
4. Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord.
Bijl HP; van Luijk P; Coppes RP; Schippers JM; Konings AW; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1204-10. PubMed ID: 16504760
[TBL] [Abstract][Full Text] [Related]
5. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
7. Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland.
Konings AW; Faber H; Cotteleer F; Vissink A; Coppes RP
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):98-105. PubMed ID: 16226398
[TBL] [Abstract][Full Text] [Related]
8. Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment.
Burlage FR; Roesink JM; Faber H; Vissink A; Langendijk JA; Kampinga HH; Coppes RP
Radiother Oncol; 2008 Mar; 86(3):347-53. PubMed ID: 18023902
[TBL] [Abstract][Full Text] [Related]
9. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
Hunt MA; Jackson A; Narayana A; Lee N
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
11. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
12. Radioprotective effect of amifostine on parotid gland functioning is region dependent.
Konings AW; Faber H; Vissink A; Coppes RP
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1584-91. PubMed ID: 16297717
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term functional vs morphometrical salivary effects of irradiation in a rodent model.
Nagler RM
Anticancer Res; 1998; 18(1A):315-20. PubMed ID: 9568096
[TBL] [Abstract][Full Text] [Related]
14. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
Houweling AC; Philippens ME; Dijkema T; Roesink JM; Terhaard CH; Schilstra C; Ten Haken RK; Eisbruch A; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1259-65. PubMed ID: 20005639
[TBL] [Abstract][Full Text] [Related]
15. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
16. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiation therapy].
Sun XN; Chen AZ; Xie CY; Jin XC; Wu SX; Zhang P; Li HB
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2289-92. PubMed ID: 17064579
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
[TBL] [Abstract][Full Text] [Related]
20. Long-term parotid gland function after radiotherapy.
Braam PM; Roesink JM; Moerland MA; Raaijmakers CP; Schipper M; Terhaard CH
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):659-64. PubMed ID: 15936542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
